SEI Investments
GPCR icon

SEI Investments’s Structure Therapeutics GPCR Stock Holding History

SEI Investments’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$734K Sell
13,684
-306
-2% -$13.5K ﹤0.01% 2467
2026
Q1 		$674K Sell
13,990
-913
-6% -$62.5K ﹤0.01% 2547
2025
Q4 		$1.04M Buy
+14,903
New +$608K ﹤0.01% 2164
2024
Q3 		– Sell
-5,395
Closed -$212K – 2716
2024
Q2 		$212K Buy
+5,395
New +$222K ﹤0.01% 2441

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

SEI Investments's GPCR Position: Q2 2026 in Review

SEI Investments reduced its Structure Therapeutics (GPCR) stake by 2.2% in Q2 2026, selling an estimated $13.5K and leaving 13,684 shares worth $734K. The position accounts for ﹤0.01% of the portfolio, ranked #2467.

SEI Investments first reported a position in GPCR in Q2 2024 and has held it in 4 quarters since. The position peaked at $1.04M in Q4 2025. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • SEI Investments held 13,684 shares of Structure Therapeutics worth $734K as of Q2 2026.
  • SEI Investments sold 306 Structure Therapeutics shares in Q2 2026, an estimated $13.5K.
  • Structure Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2467 holding.
  • SEI Investments first reported a position in Structure Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • SEI Investments's Structure Therapeutics position peaked at $1.04M in Q4 2025.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.